Novel PSMA targeting alpha-emitting radioligand [211At]PSAt-3-Ga inhibits tumor growth and increases survival in a preclinical model of human xenograft prostate cancer.
Saved in:
| Title: | Novel PSMA targeting alpha-emitting radioligand [211At]PSAt-3-Ga inhibits tumor growth and increases survival in a preclinical model of human xenograft prostate cancer. |
|---|---|
| Authors: | Hvass, Lars1,2 (AUTHOR) Lars.hvass@sund.ku.dk, Müller, Marius3 (AUTHOR) marius.muller@sund.ku.dk, Shalgunov, Vladimir3 (AUTHOR), Clausen, Anne S.1,2 (AUTHOR), Poulie, Christian B. M.3 (AUTHOR), Aneheim, Emma4 (AUTHOR), Jensen, Holger J.2 (AUTHOR), Herth, Matthias M.2,3 (AUTHOR), Kjaer, Andreas1,2 (AUTHOR) |
| Source: | EJNMMI Research. 1/27/2026, Vol. 16 Issue 1, p1-7. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2191219X |
|---|---|
| DOI: | 10.1186/s13550-026-01378-z |
